Upgrade to SI Premium - Free Trial

TCR2 Therapeutics (TCRR) PT Lowered to $20 at Mizuho Securities

October 21, 2021 6:39 AM
Mizuho Securities analyst Mara Goldstein ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst PT Change

Next Articles